The Effect of a Low-calorie Diet With Balanced Nutrition to Metabolic Syndrome

January 19, 2023 updated by: Nur Indrawaty Lipoeto, Andalas University

The Effect of a Nutritionally Balanced Low-calorie Diet Based on the Archipelago Diet on Metabolic Biomarkers of Health Workers Suffering From Obesity.

The study examined the effect of a nutritionally balanced low-calorie diet based on the archipelago diet on metabolic biomarkers of health workers suffering from obesity. The archipelago diet given is the food of the Minangkabau people. Metabolic biomarkers assessed include body mass index, waist circumference, blood pressure, body fat mass percentage, fasting blood sugar levels and lipid profiles. Researchers hypothesize the provision of a balanced nutrition low-calorie diet based on an archipelago diet will have a significant effect on the metabolic biomarkers of health workers suffering from obesity.

Study Overview

Detailed Description

The study was conducted at RSUP dr. M. Djamil Padang. The study has obtained an ethical permit from the research ethics commission of the Faculty of Medicine of Andalas University. Health workers with a body mass index of more than 25 kg/m2 became the study population and officers who were willing to take part in the study were included in the study after filling out the inform consent. The study participants numbered 50 people. The study was conducted for 8 weeks (56 days). A week before the study participants were interviewed about daily intake using 24-hour food recall and anthropometric measurements were carried out using tools that had been calibrated and carried out by trained officers. Anthropometric measurements were carried out as many as 3 repetitions and taken on average. Subjects underwent a one-week pre-treatment period (baseline period, starting from D-day 6 to day 0), with a diet as the subject's habit and were asked not to take any kind of supplement. On day 0 and day 57, all participants were checked for blood pressure, body fat percentage, fasting blood sugar levels and lipid profile. Post-interventional anthropometric examination was also carried out on day 57. The daily intake of participants obtained through a 24-hour food recall interview was processed with the Nutrisurvey 2005 application. Dietary interventions were given with a calorie deficit of 500-600 kcal from the participants' usual daily intake. The diet is given with a Minangkabau food menu. Participants are made a list of daily menus, including breakfast, lunch and dinner. Researchers provided lunch for study participants while breakfast and dinner were prepared independently by participants according to the dietary guidelines and menus provided. Participants recorded daily intake using a food diary, collected and evaluated every 2 times a week. All participants are also always controlled and motivated by the research team through whattsapp groups. The results of the study were processed with SPSS aplication.

Study Type

Interventional

Enrollment (Actual)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Sumatera Barat
      • Padang, Sumatera Barat, Indonesia
        • Universitas Andalas

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Employee of RSUP dr. M. Djamil, Padang who suffers from obesity (BMI ≥ 25 kg / m2)
  • Willing to follow the research by signing an informed concent

Exclusion Criteria:

  • Did not come and could not be found at the time of research data collection
  • Unable to follow the dietary arrangements as set
  • Taking anti-diabetic or anti-lipid drugs
  • Use of contraceptives or hormonal drugs
  • In the treatment of radiotherapy or chemotherapyi

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nutritionally balanced low-calorie diet
Experimental study with pre and post design
Dietary interventions were given with a calorie deficit of 500-600 kcal from the participants' usual daily intake.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline body mass index at 8 weeks.
Time Frame: up to 8 weeks
A person's weight in kilograms divided by the square of height in meters
up to 8 weeks
Change from baseline waist circumference at 8 weeks.
Time Frame: up to 8 weeks
The measurement taken around the abdomen at the level of the umbilicus (belly button).
up to 8 weeks
Change from baseline blood pressure at 8 weeks.
Time Frame: up to 8 weeks
Measured using a digital sphygmomanometer
up to 8 weeks
Change from baseline fat mass percentage at 8 weeks.
Time Frame: up to 8 weeks
Measured using bioimpedance analysis (BIA)
up to 8 weeks
Change from baseline fasting blood sugar levels at 8 weeks.
Time Frame: up to 8 weeks
Measured using clinical chemistry analyzer
up to 8 weeks
Change from baseline lipid profile levels at 8 weeks.
Time Frame: up to 8 weeks
The lipid profile examined included total cholesterol, triglycerides, HDL (high density lipoprotein) cholesterol, and LDL (low density lipoprotein) cholesterol. Measured using clinical chemistry analyzer (photometer).
up to 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nurindrawaty Lipoeto, PhD, Universitas Andalas

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 5, 2022

Primary Completion (Actual)

December 4, 2022

Study Completion (Actual)

December 4, 2022

Study Registration Dates

First Submitted

December 5, 2022

First Submitted That Met QC Criteria

January 19, 2023

First Posted (Estimate)

January 30, 2023

Study Record Updates

Last Update Posted (Estimate)

January 30, 2023

Last Update Submitted That Met QC Criteria

January 19, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Yes

IPD Plan Description

all IPD that underlie results in a publication

IPD Sharing Time Frame

Starting 6 months after publication for 1 year

IPD Sharing Access Criteria

other researcher can contact us trough e-mail.

IPD Sharing Supporting Information Type

  • Study Protocol

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Metabolic Syndrome, Protection Against

Clinical Trials on Nutritionally balanced low-calorie diet

3
Subscribe